Israeli wheelchair player suspended for doping

March 2, 2006 20:08


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


Wheelchair tennis player Ilanit Fridman was suspended on Thursday for one month after testing positive for a banned substance. The 29-year-old Israeli player tested positive for terbutaline, a drug used to treat asthma, at the US Open Wheelchair Tennis Championships in San Diego on October 5. An independent tribunal ruled that Fridman committed a doping offense, but found no intent on her part to use the drug to enhance performance. That charge would have carried a two-year ban. The ITF said Fridman was at fault for failing to ensure that she had a "Therapeutic Use Exemption" allowing her to take the drug.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

Jisr az-Zarq
April 3, 2014
Residents of Jisr az-Zarqa beckon Israel Trail hikers to enjoy their town